通化金马 (000766)
TONGHUA GOLDEN-HORSE PHARMACEUTICAL INDUSTRY CO,LTD
K-Line Chart
No K-line data available
Company NameTonghua Jinma Pharmaceutical Group Co., Ltd.
Listing Date1997-04-30
Issue Price7.23RMB
Registered Capital96649.470710k RMB
Legal RepresentativeZhang Yufu
Registered AddressNo. 999 Jinma Road, Erdaojiang District, Tonghua City, Jilin Province
IndustryChemical Pharmaceuticals
Main BusinessResearch, development, production, and sales of pharmaceutical products.
Company ProfileTonghua Jinma Pharmaceutical Group Co., Ltd. is one of the earliest listed pharmaceutical companies in China. It possesses first-class standard factory buildings, GMP production lines, and a quality management system, operating as a comprehensive pharmaceutical enterprise integrating drug production, sales, and R&D. It has been repeatedly recognized as one of China's Top 100 Traditional Chinese Medicine Manufacturers, one of China's Top 100 Pharmaceutical Industrial Enterprises, and one of China's Top 50 Fastest-Growing Pharmaceutical Companies. Its products have been awarded the "Famous Brand" title multiple times by the Development Research Center of Jilin Provincial People's Government, the Jilin Provincial Quality Management Association, and the Jilin Provincial Drug Quality Supervision and Administration. The company has been awarded the title of National Advanced Collective in the Pharmaceutical System by the National Medical Products Administration, designated as a Provincial High-Tech Enterprise by the provincial government, and recognized as a Well-Known Pharmaceutical Enterprise in the industry by the Provincial Science and Technology Commission and the Provincial Drug Administration.
Stock Details
1. Key Indicators
- Total Shares(W): 96649.47
- Circulating A-Shares(W): 96600.77
- Earnings Per Share(RMB): 0.0258
- Net Assets Per Share(RMB): 2.3810
- Operating Revenue(W RMB): 89225.11
- Total Profit(W RMB): 3458.83
- Net Profit Attributable to Parent(W RMB): 2496.35
- Net Profit Growth Rate(%): 4.35
- Weighted Return on Equity(%): 1.1000
- Operating Cash Flow Per Share(RMB): 0.0730
- Undistributed Profit Per Share(RMB): -2.3336
- Capital Reserve Per Share(RMB): 3.7034
2. Main Business
The main business covers:
- R&D, production and sales of pharmaceutical products
3. Company Basic Information
- Company Name: Tonghua Golden-horse Pharmaceutical Industry Co., Ltd.
- Listing Date: 1997-04-30
- Industry: Pharmaceutical Manufacturing
- Address: No. 999 Jinma Road, Erdaojiang District, Tonghua City, Jilin Province
- Website: www.thjm.cn
- Company Profile：The company was jointly established in 1993 by three enterprises including Tonghua Biochemical Pharmaceutical Factory. Initially, the net assets of the promoters were converted into 31.196 million state shares and 36.929 million legal person shares. 20.575 million private placement legal person shares and 55.1 million employee shares were issued. After a 1:0.6 share consolidation on December 21, 1996, and the first online pricing issuance on April 18, 1997, the total number of shares at the time of listing was 126.28 million.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Shanghai Mukai Trading Co., Ltd. | General Legal Person | 4699.20 | 4.86 |
| 2 | Tonghua Yongxin Investment Co., Ltd. | General Legal Person | 2000.00 | 2.07 |
| 3 | Yinhua CSI Innovative Pharmaceutical Industry ETF | Fund | 919.30 | 0.95 |
| 4 | Southern CSI 1000 ETF | Fund | 884.16 | 0.92 |
| 5 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 726.71 | 0.75 |
| 6 | ChinaAMC CSI 1000 ETF | Fund | 525.31 | 0.54 |
| 7 | Huafu CSI 300 Index Enhanced Securities Investment Fund Class A | Fund | 3.30 | 0.00 |
| 8 | <值> | <值> | <值> | <值> |
| 9 | <值> | <值> | <值> | <值> |
| 10 | <值> | <值> | <值> | <值> |
5. Concept Sectors
- Private Hospital
- Industrial Hemp
- Hepatitis Concept
- Innovative Drug
- DeepSeek
- Margin Trading & Securities Lending
- High P/E Ratio
- Long-term No Dividend
- Non-Cyclical Stock
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information